Assessing the Accuracy of an Electronic Platform for Childhood Illnesses Management in Rual China: A Cluster Randomized Controlled Trial (Preprint)

Author:

Health PuhongORCID,Yang Zhao Yang Zhao,Jie Shang Jie,Nadila Duolikun,Li Tao,Liu YuORCID,Abdurixit Gulizat,Hirst Jane ElizabethORCID

Abstract

BACKGROUND

The Integrated Management of Childhood Illness (IMCI) faces challenges like high training costs and limited literacy among community health workers (CHWs), resulting in low adherence. Electronic IMCI (eIMCI) platforms with training modules may address these limitations but require further evaluation.

OBJECTIVE

This study aims to evaluate an eIMCI platform for training support and disease management in rural China.

METHODS

A cluster randomized controlled trial was conducted in western China. 24 CHWs and 72 children aged 2-5 years treated by them (3 per CHW) were randomized into intervention and control groups. The intervention group received online training and used the eIMCI platform for disease management. The control group received traditional in-person training and paper-based IMCI. The primary outcome was the proportion of children correctly diagnosed/classified by the CHWs as deemed by a pediatric specialist. Poisson regression with Generalized Linear Models estimated the relative risk (RR) between groups, adjusting for CHW clustering, CHW variables (age, sex, education), and patient variables (age, sex, disease number).

RESULTS

13 CHWs treated 39 children in the intervention group, and 11 CHWs treated 33 children in the control group. Correct classification was significantly higher in the intervention versus control group (64.1% vs 39.4%, P=.036). Multivariable regression confirmed this improvement (RR=2.10, 95% CI: 1.45-3.06; P<.001). Correct treatment increased non-significantly (38.5% vs 27.3%, P=.316). Online training reduced time and costs by ~80% but with a minor decline in post-training scores.

CONCLUSIONS

With substantially lower training burden, the eIMCI platform demonstrated potential to improve IMCI in rural China.

CLINICALTRIAL

Chinese Clinical Trial Registry: ChiCTR2100042533 (https://www.chictr.org.cn/showproj.html?proj=119995)

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3